 |
|
Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):790-801. Published online 2022 May 11 DOI: https://doi.org/10.3350/cmh.2022.0070
|
|
Citations to this article as recorded by
 Serum remnant cholesterol is a potential predictor of liver stiffness in patients with nonalcoholic fatty liver disease
Ya Wang, Wanhan Song, Qianhua Yuan, Meiqing Mai, Mengliu Luo, Jiahua Fan, Peiwen Zhang, Honghui Guo
Scandinavian Journal of Gastroenterology.2024; 59(4): 469. CrossRef Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
Metabolism.2024; 152: 155789. CrossRef Association of composite dietary antioxidant index and muscle mass in individuals with metabolic associated fatty liver disease
Jing Guo, Lin Shi, Yan Sun
Clinics and Research in Hepatology and Gastroenterology.2024; 48(2): 102284. CrossRef Integrative insights into cerebrometabolic disease: Understanding, management, and future prospects
Gaili Yan, Xiangyu Zhang, Yang Liu, Pingping Guo, Yuanyuan Liu, Xin Li, V. Wee Yong, Mengzhou Xue
Journal of Neurorestoratology.2024; 12(2): 100107. CrossRef Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1
Chaoyuan Huang, Qiuhong Yong, Yihui Lu, Lu Wang, Yiyuan Zheng, Lina Zhao, Peiwu Li, Chong Peng, Wei Jia, Fengbin Liu
Frontiers in Pharmacology.2024;[Epub] CrossRef Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, Dae Won Jun, Ki Tae Yoon, Young Youn Cho, Hoon Gil Jo, Ae Jeong Jo
Gut and Liver.2024; 18(2): 283. CrossRef Differences in the prevalence of NAFLD, MAFLD, and MASLD according to changes in the nomenclature in a health check-up using MRI-derived proton density fat fraction
Hee Jun Park, Sunyoung Lee, Jae Seung Lee
Abdominal Radiology.2024;[Epub] CrossRef Alteration of Gut Microbiota Composition in the Progression of Liver Damage in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Alejandra Zazueta, Lucía Valenzuela-Pérez, Nicolás Ortiz-López, Araceli Pinto-León, Verónica Torres, Danette Guiñez, Nicolás Aliaga, Pablo Merino, Alexandra Sandoval, Natalia Covarrubias, Edith Pérez de Arce, Máximo Cattaneo, Alvaro Urzúa, Juan Pablo Robl
International Journal of Molecular Sciences.2024; 25(8): 4387. CrossRef Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities
Muhammed Mubarak
World Journal of Gastrointestinal Pathophysiology.2024;[Epub] CrossRef Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
Jingxuan Quek, Kai En Chan, Zhen Yu Wong, Caitlyn Tan, Bryan Tan, Wen Hui Lim, Darren Jun Hao Tan, Ansel Shao Pin Tang, Phoebe Tay, Jieling Xiao, Jie Ning Yong, Rebecca Wenling Zeng, Nicholas W S Chew, Benjamin Nah, Anand Kulkarni, Mohammad Shadab Siddiqu
The Lancet Gastroenterology & Hepatology.2023; 8(1): 20. CrossRef The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals
Kai En Chan, Cheng Han Ng, Clarissa Elysia Fu, Jingxuan Quek, Gwyneth Kong, Yi Jie Goh, Rebecca Wenling Zeng, Michael Tseng, Manik Aggarwal, Benjamin Nah, Douglas Chee, Zhen Yu Wong, Sitong Zhang, Jiong-Wei Wang, Nicholas W.S. Chew, Yock Young Dan, Mohamm
Clinical Gastroenterology and Hepatology.2023; 21(10): 2560. CrossRef Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD – An Umbrella Overview of Systematic Review of Meta-Analysis
Jieling Xiao, Cheng Han Ng, Kai En Chan, Clarissa Fu, Phoebe Tay, Jie Ning Yong, Wen Hui Lim, Darren Jun Hao Tan, Nicholas Syn, Zhen Yu Wong, Michael Tseng, Nicholas Chew, Daniel Q. Huang, Yock Yong Dan, Vincent Wai-Sun Wong, Rohit Loomba, Mohammad S. Sid
Journal of Clinical and Experimental Hepatology.2023; 13(4): 656. CrossRef Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, Jieling Xiao, Jie Ning Yong, Bryan Tan, Nicholas Syn, Jiong-Wei Wang, Nilofer Sayed, Eunice Tan, Nicholas WS Chew, Yock Young Dan, Mo
Annals of Hepatology.2023; 28(1): 100762. CrossRef Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
Liver International.2023; 43(3): 608. CrossRef Examining the interim proposal for name change to steatotic liver disease in the US population
Cheng Han Ng, Kai En Chan, Mark Muthiah, Caitlyn Tan, Phoebe Tay, Wen Hui Lim, Darren Jun Hao Tan, Clarissa Elysia Fu, Jie Ning Yong, Zhen Yu Wong, Benjamin Koh, Nicholas WS Chew, Nicholas Syn, Daniel Q. Huang, Yock Young Dan, Mohammad S. Siddiqui, Arun J
Hepatology.2023; 77(5): 1712. CrossRef Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Hye Won Lee
Clinical and Molecular Hepatology.2023; 29(1): 169. CrossRef Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, Pietro Lampertico, Maria Buti, Claude B. Sirlin, Mindie H. Nguyen, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology.2023; 20(12): 797. CrossRef Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S43. CrossRef The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
George Chen, Bubu Banini, Albert Do, Joseph K. Lim
Clinical and Molecular Hepatology.2023; 29(Suppl): S319. CrossRef MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
Clinical and Molecular Hepatology.2023; 29(Suppl): S17. CrossRef Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clinical and Molecular Hepatology.2023; 29(Suppl): S5. CrossRef Global epidemiology of cirrhosis — aetiology, trends and predictions
Daniel Q. Huang, Norah A. Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology.2023; 20(6): 388. CrossRef Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus—The Chicken or the Egg Dilemma
Marcin Kosmalski, Agnieszka Śliwińska, Józef Drzewoski
Biomedicines.2023; 11(4): 1097. CrossRef Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clinical and Molecular Hepatology.2023; 29(2): 320. CrossRef The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Clinical and Molecular Hepatology.2023; 29(2): 374. CrossRef The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Young-Joo Jin
Clinical and Molecular Hepatology.2023; 29(2): 414. CrossRef Correlation of the pediatric metabolic index with NAFLD or MAFLD diagnosis, and serum adipokine levels in children
Maria-Luisa Lazo-de-la-Vega-Monroy, Monica-del-Carmen Preciado-Puga, Yeniley Ruiz-Noa, Marcia Salum-Zertuche, Lorena-del-Rocio Ibarra-Reynoso
Clinics and Research in Hepatology and Gastroenterology.2023; 47(6): 102137. CrossRef MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
Jung Wook Seo, Youe Ree Kim, Jong Keon Jang, So Yeon Kim, Young Youn Cho, Eun Sun Lee, Dong Ho Lee
Ultrasonography.2023; 42(3): 421. CrossRef Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
Byeong Geun Song, Sung Chul Choi, Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Seung Woon Paik
JHEP Reports.2023; 5(9): 100810. CrossRef The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study
Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu
European Journal of Gastroenterology & Hepatology.2023; 35(8): 889. CrossRef Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity
Jung Gil Park
Gut and Liver.2023; 17(4): 489. CrossRef Saponins of Tomato Extract Improve Non-Alcoholic Fatty Liver Disease by Regulating Oxidative Stress and Lipid Homeostasis
Ziming Yang, Li Zhang, Jinlei Liu, Albert S. C. Chan, Dianpeng Li
Antioxidants.2023; 12(10): 1848. CrossRef Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China
Mingxing Chang, Zhihao Shao, Wei Wei, Peipu Shen, Guifang Shen
Frontiers in Endocrinology.2023;[Epub] CrossRef New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeongjun Song
Nutrients.2023; 15(18): 3970. CrossRef Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
Pei Zeng, Xiangsheng Cai, Xiaozhou Yu, Linjing Gong
Scientific Reports.2023;[Epub] CrossRef A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population
Chih-Yi Ho, Jia-In Lee, Shu-Pin Huang, Szu-Chia Chen, Jiun-Hung Geng
Nutrients.2023; 16(1): 77. CrossRef Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
Nan Yao, Yixue Yang, Xiaotong Li, Yuxiang Wang, Ruirui Guo, Xuhan Wang, Jing Li, Zechun Xie, Bo Li, Weiwei Cui
Frontiers in Nutrition.2022;[Epub] CrossRef The clinical impact of an extra virgin olive oil enriched mediterranean diet on metabolic syndrome: Lights and shadows of a nutraceutical approach
Aurelio Seidita, Maurizio Soresi, Lydia Giannitrapani, Vita Di Stefano, Roberto Citarrella, Luigi Mirarchi, Antonella Cusimano, Giuseppa Augello, Antonio Carroccio, Juan Lucio Iovanna, Melchiorre Cervello
Frontiers in Nutrition.2022;[Epub] CrossRef Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH
Darren Jun Hao Tan, Veronica Wendy Setiawan, Cheng Han Ng, Wen Hui Lim, Mark D. Muthiah, Eunice X. Tan, Yock Young Dan, Lewis R. Roberts, Rohit Loomba, Daniel Q. Huang
Hepatology.2022; : n/a. CrossRef The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population
Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung
Journal of Cachexia, Sarcopenia and Muscle.2022; 13(6): 2953. CrossRef Association between flavonoid and subclasses intake and metabolic associated fatty liver disease in U.S. adults: Results from National Health and Nutrition Examination Survey 2017–2018
Junlu Tong, Yingjuan Zeng, Jianhui Xie, Kecen Xiao, Man Li, Li Cong
Frontiers in Nutrition.2022;[Epub] CrossRef Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes
Xiaodan Zhang, Yimei Chen, Huiyu Ye, Zirui Luo, Jiahong Li, Zhishan Chen, Enting Zhang, Wangen Li
Endocrine.2022; 80(2): 366. CrossRef
|